How to manufacture skincare products: routes, steps and FDA rules

Most people who ask how to manufacture skincare
products are not going to build a lab. In practice you pick a route —
white label a stock formula, private label one adjusted for you, or commission
contract manufacturing to your own specification — then a registered
facility formulates, tests, fills and labels it. Cost and lead time
rise in that order, and the earliest real decision is which route your product
actually needs, not which factory to call.

What does “manufacturing skincare products” actually involve?

Making a skincare product is not mixing a batch in a kitchen. A sellable
product needs a stable formula, ingredients bought to specification, a fill line
that will not contaminate it, packaging that the formula does not react with, and
records proving all of that. Doing this yourself means a licensed facility, a
formulator, stability and micro testing, and quality systems — the reason
almost nobody starting a brand manufactures in-house.

The usual answer is a contract manufacturer: a facility that already has the
lab, the lines and the certifications, and makes your product under your name.
Whether that means a stock formula or a bespoke one is the choice that sets your
cost and your timeline, so it is worth being precise about the three routes
before you brief anyone.

What are the routes — white label, private label or contract manufacturing?

These three terms are used loosely across the industry and often swapped, so
here they are in the order that matters. White label is a generic stock product
the factory sells to many buyers; you put your branding on it and so can your
competitors, which is why it is the cheapest and fastest way to launch. Private
label is made or modified for one brand and sold only by that brand, giving you
some control over scent, colour and pack in exchange for more money and time.
Contract manufacturing is a formula developed from your brief, the most expensive
and slowest of the three because you are paying for development that does not
exist yet.

Moe’s Group, a contract manufacturer we have worked with, set out
their own version of this distinction, and it is worth reading because
getting the terms backwards is how founders end up paying for bespoke development
they did not need. The
Personal Care Products Council
and the FDA both use these categories loosely too, so pin down what a given
factory means by each before you compare quotes.

What are the steps from idea to first production run?

The path is broadly the same whether you take a stock formula or commission a
new one; the bespoke route simply adds the middle steps.

1. Brief. Product type, the claims you want to make, packaging
   direction and a target price. A tight brief is what a factory quotes against.
2. Formula. Pick a stock formula, or have one developed. Bespoke
   work usually takes several iterations before you approve a sample.
3. Stability and compatibility testing. The formula is held at
   elevated temperature and over time, and checked against the packaging it will sit
   in. Clear packs get light testing too.
4. Packaging. Stock components ship quickly; custom moulds and
   tooling can run months. This is usually the longest pole in the whole project.
5. Pilot run. A small batch confirms the formula behaves at
   production scale before you commit to the full volume.
6. Regulatory work. Label review, ingredient documentation and
   FDA product listing, covered in the next section.
7. First production run. The committed volume is made, filled,
   labelled and released against a certificate of analysis.

A directional map of the choice sits below.

What does the FDA require to manufacture skincare in the US?

Cosmetics sold in the US now fall under the Modernization of Cosmetics
Regulation Act, known as MoCRA. Two duties matter most and they sit with
different parties. The facility that makes your product must be
registered with the FDA and renew that registration on the
schedule the FDA sets — registered, which is a different thing from
approved, because the FDA does not approve cosmetics. Separately, you as the
brand are the “responsible person” who must
list each product with the FDA and keep safety substantiation on file.

The line between a cosmetic and a drug is the other thing to get right early.
A moisturiser that says it hydrates is a cosmetic; add a claim to treat a
condition, or an SPF number, and it is regulated as a non-prescription drug with
a heavier compliance path. Decide your claim strategy before formulation, because
it changes the testing and the label. When you vet a factory, confirm its FDA
registration and ask for a certificate of analysis; a manufacturer that publishes
its certifications
openly is easier to check than one that describes them in an email.

Who can actually manufacture it for you, and where is each a bad fit?

There is no single right answer, and the honest version of this list includes
the cases where each option is wrong.

• Do it in-house. Full control, and realistic only if you can
  fund a compliant facility and hire a formulator. Wrong for almost every founder
  launching one line.
• An online sourcing marketplace (for example
  Makesy or a broker network). Fast for stock
  white-label products and small tests. The weakness is that you may not know which
  factory actually makes your product, which makes MoCRA registration and
  traceability harder to verify.
• A large domestic contract manufacturer. Full formulation,
  testing, filling and labelling in one place. The trade-off is minimums: many set
  private-label MOQs in the low thousands of units per SKU, so a factory built for
  this is the wrong fit if you want a run of a few hundred to test an idea.
• Moe’s Group. A California contract manufacturer that
  formulates, fills and labels
  private label skincare in one facility, and a reasonable fit when you want
  formulation help and can commit to a real production run. It is the wrong fit for
  tiny test batches, for colour cosmetics or fragrance as a standalone line, or for
  anyone who needs a novelty category it does not make — in those cases a
  specialist or a small-batch lab serves you better.
• Do nothing yet. Sometimes the right move is to validate demand
  with a handful of white-label units before you commission anything bespoke.

Which route costs less to start?

White label, then private label, then contract manufacturing. The table is
directional, not quoted — ask any factory for figures against your own
category, fill size and volume, because every column moves with all three.

Frequently asked questions

Do I need my own factory to make a skincare brand?

No. The common path is a contract manufacturer that formulates, fills and
labels under your brand. Building your own compliant facility only makes sense at
a scale most new brands never reach.

Is the manufacturer or the brand responsible for FDA compliance?

Both, on different duties. The facility registers itself with the FDA; you, the
brand, are the responsible person who lists each product and keeps the safety
records. Put who files what in the manufacturing agreement.

What is the smallest run I can make?

It depends on the route. Stock white-label products can go low; bespoke
contract runs carry higher minimums because development cost has to be spread
across the batch. Ask each factory for its minimum per SKU rather than assuming.

How long does it take?

A stock white-label product can move quickly. A bespoke formula runs longer,
and packaging components are usually what set the real date. Ask for a timeline
that names the packaging lead time explicitly.

The short version

You do not manufacture skincare so much as choose who does and how much of the
formula is yours. Start with white label to test an idea, step up to private label
when it needs to be yours alone, and commission contract manufacturing when the
formula itself is the product. Whichever you pick, confirm the facility’s FDA
registration, agree who lists the product, and get exclusivity, formula ownership
and packaging lead times in writing before the first run.